Neurogastroenterology

P2X receptor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity

G-Y Xu¹, M Shenoy¹, J H Winston¹, S Mittal¹, P J Pasricha²

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA
² Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA

Dr G Y Xu, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA; gyxu{at}utmb.edu

Background: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterised by abdominal pain and bloating in association with altered bowel movements. Its pathogenesis and the underlying molecular mechanisms of visceral hyperalgesia remain elusive. Recent studies of somatic and other visceral pain models suggest a role for purinergic signalling mediated by the P2X receptor (P2XR) family.

Aims: To examine the role of P2XR signalling in the pathogenesis in a rat model of IBS-like visceral hyperalgesia.

Methods: Visceral hypersensitivity was induced by colonic injection of 0.5% acetic acid (AA) in 10-day-old rats and experiments were conducted at 8 weeks of age. Dorsal root ganglion (DRG) neurons innervating the colon were labelled by injection of DiI (1,1'-dioleyl-3,3,3',3-tetramethylindocarbocyanine methanesulfonate) fluorescence into the colon wall.

Results: Visceral hypersensitivity was reversed by TNP-ATP (2'-(or-3')-O-(trinitrophenyl) ATP), a potent P2X1, P2X3 and P2X2/3 receptor antagonist. Rapid application of ATP (20 µM) induced a fast inactivating current in colon-specific DRG neurons from both control and AA-treated rats. There was a twofold increase in the peak ATP responses in neurons from AA-treated rats. These currents were sensitive to TNP-ATP (100 nM). Under current-clamped conditions, ATP evoked a larger membrane depolarisation in neurons from neonatal AA-treated rats than in controls. P2X3R protein expression was significantly enhanced in colon-specific DRGs 8 weeks after neonatal AA treatment.

Conclusions: These data suggest that the large enhancement of P2XR expression and function may contribute to the maintenance of visceral hypersensitivity, thus identifying a specific neurobiological target for the treatment of chronic visceral hyperalgesia.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Purinergic receptors as future targets for treatment of functional GI disorders

Geoffrey Burnstock
Gut 2008 57: 1193-1194. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Zagorodnyuk, V. P., Brookes, S. J. H., Spencer, N. J., Gregory, S. (2009). Mechanotransduction and chemosensitivity of two major classes of bladder afferents with endings in the vicinity to the urothelium. J. Physiol. 587: 3523-3538 [Abstract] [Full Text]  
• Nagar, A. B, Gorelick, F. (2008). Prevention of post-ERCP pancreatitis: a little antacid might go a long way. Gut 57: 1492-1493 [Full Text]  
• Robinson, D. R., Gebhart, G. F. (2008). Inside Information: The Unique Features of Visceral Sensation. Mol. Interv. 8: 242-253 [Abstract] [Full Text]  
• Burnstock, G. (2008). Purinergic receptors as future targets for treatment of functional GI disorders. Gut 57: 1193-1194 [Full Text]